메뉴 건너뛰기




Volumn 24, Issue 15, 2006, Pages 2395-2396

Aggressive surgery and ovarian cancer [5]

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CARBOPLATIN; DOCETAXEL; PACLITAXEL; ANTINEOPLASTIC AGENT;

EID: 33744793490     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.4890     Document Type: Letter
Times cited : (8)

References (5)
  • 1
    • 33644845467 scopus 로고    scopus 로고
    • Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 trial
    • Crawford SC, Vasey PA, Paul J, et al: Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 trial. J Clin Oncol 23:8802-8811, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 8802-8811
    • Crawford, S.C.1    Vasey, P.A.2    Paul, J.3
  • 2
    • 9744223515 scopus 로고    scopus 로고
    • Phase III randomized trial of docetaxel-carboplatin as first-line chemotherapy for ovarian carcinoma
    • Vasey PA, Jayson GC, Gordon A, et al: Phase III randomized trial of docetaxel-carboplatin as first-line chemotherapy for ovarian carcinoma. J Natl Cancer Inst 96:1682-1691, 2004
    • (2004) J Natl Cancer Inst , vol.96 , pp. 1682-1691
    • Vasey, P.A.1    Jayson, G.C.2    Gordon, A.3
  • 3
    • 0034823377 scopus 로고    scopus 로고
    • Identification of prognostic factors in advanced epithelial ovarian carcinoma
    • Chi DS, Liao JB, Venkatraman ES, et al: Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol 82:532-537, 2001
    • (2001) Gynecol Oncol , vol.82 , pp. 532-537
    • Chi, D.S.1    Liao, J.B.2    Venkatraman, E.S.3
  • 4
    • 0141688377 scopus 로고    scopus 로고
    • Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study
    • Ozols RF, Bundy BN, Greer BE, et al: Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study. J Clin Oncol 21:3194-3200, 2003
    • (2003) J Clin Oncol , vol.21 , pp. 3194-3200
    • Ozols, R.F.1    Bundy, B.N.2    Greer, B.E.3
  • 5
    • 84871469838 scopus 로고    scopus 로고
    • What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma
    • abstr 56
    • Chi DS, Huh J, Haddad L, et al: What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma. Gynecol Oncol 96:934-935 (abstr 56)
    • Gynecol Oncol , vol.96 , pp. 934-935
    • Chi, D.S.1    Huh, J.2    Haddad, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.